Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution

  • HEMANGEOL is now available exclusively through Anovo Specialty Pharmacy to streamline access and therapy initiation
  • Eton has integrated full Eton Cares patient support, including $0 co-pay for eligible commercially insured patients and expanded patient assistance programs
  • HEMANGEOL is the only FDA-approved treatment for infantile hemangioma, a pediatric rare disease that can be time-sensitive

DEER PARK, Ill., May 01, 2026 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the relaunch of HEMANGEOL®.

“We are excited to deliver another major product launch for the company. HEMANGEOL is a critical and time-sensitive therapy where early treatment can meaningfully impact outcomes, and the only FDA-approved treatment for infantile hemangiomas. With the integration of Eton Cares and a dedicated rare disease specialty pharmacy model, we are focused on helping patients start therapy quickly and ensuring families are supported from prescription through treatment. Our HEMANGEOL commercial team has been actively working with caregivers, healthcare professionals, and pharmacies to ensure a seamless transition for patients,” said Sean Brynjelsen, CEO of Eton Pharmaceuticals.

“Infantile hemangiomas can evolve rapidly, and timely intervention is critical. In practice, the challenge is often not recognizing when to treat but ensuring that infants can start therapy without delays. Streamlined access to an FDA-approved treatment designed specifically for this population can meaningfully improve both outcomes and the care experience for families,” said Dr. Maria Gnarra Buethe, MD, PhD, Division Chief of Dermatology, Rady Children’s Hospital of Orange County and Director of Pediatric Dermatology, University of California, Irvine.

Dr. Kristi Derrick, MD, ScM, Clinical Assistant Professor, SUNY Downstate Health Sciences University (NY) and Paragon Skin Dermatology (NJ) added, “Infantile hemangiomas are common, but in some cases these skin lesions need to be treated urgently to prevent complications and provide the best cosmetic outcome. When a baby has an infantile hemangioma on the face, scalp, diaper area, skin folds or large or multiple lesions, it is important that the baby can get into a specialist quickly to discuss treatment options.”

“For families, an infantile hemangioma diagnosis is overwhelming and the window of opportunity to potentially prevent negative consequences is narrow. In order to prevent these adverse complications, prompt and early treatment is critical. At the Vascular Birthmarks Foundation, we advocate starting treatment as soon as the lesion is diagnosed. We strongly lobby for all primary care doctors to initiate HEMANGEOL treatment as soon as medically feasible,” said Dr. Linda Rozell- Shannon, Founder & President of The Vascular Birthmarks Foundation, a global non-profit that has networked over 150,000 patients with vascular malformations into treatment for over 30 years.

HEMANGEOL is an orphan drug indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. Infantile hemangiomas are non-cancerous vascular tumors which typically appear in the first days or weeks of a newborn’s life. In severe cases, infantile hemangiomas can lead to more serious complications, and require intervention with systemic therapy. Treatment with HEMANGEOL is typically initiated between five weeks to five months of age, and continues for approximately six months, representing a critical window where timely intervention can prevent complications and improve outcomes. It is estimated that approximately 5,000-10,000 infants are treated with HEMANGEOL annually in the United States.

Clinicians seeking to prescribe HEMANGEOL can e-prescribe by selecting Anovo #5 (Memphis) or fax a patient referral form to 855-813-2039. Patients with questions regarding their prescription or healthcare providers can call Anovo at the dedicated HEMANGEOL line 833-486-5950. Additional product details can be found on the product website, https://www.hemangeol.com.


Ref:

American Academy of Pediatrics. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics. January 2019.

USE

HEMANGEOL (propranolol hydrochloride) oral solution is a prescription medicine used to treat proliferating infantile hemangioma (a type of birthmark) requiring treatment throughout the body.

Who should NOT take HEMANGEOL?

Do not give HEMANGEOL to your child if they:

  • Were born early and are less than 5 weeks corrected age
  • Weigh less than 4.5 lbs
  • Have asthma or a history of breathing problems (bronchospasm)
  • Have certain heart conditions (such as slow heart rate, heart block, or heart failure)
  • Have very low blood pressure
  • Have high blood pressure caused by a tumor on the adrenal gland, called “pheochromocytoma”
  • Are allergic to propranolol or any of the ingredients in HEMANGEOL

IMPORTANT SAFETY INFORMATION

HEMANGEOL may cause serious side effects, including:

Low blood sugar (hypoglycemia), which can be serious and may lead to seizures, loss of consciousness, or even death. This is more likely if your child is not eating well, is vomiting, or is sick. Always give HEMANGEOL during or right after feeding. Do not give a dose if your child is not eating. Signs of low blood sugar may include pale skin, sweating, irritability, unusual sleepiness, or seizures.

Bradycardia and hypotension. HEMANGEOL may slow your child’s heart rate or lower their blood pressure. Call your healthcare provider if your child seems unusually tired, dizzy, faints, or has pale or cold skin.

Bronchospasm. HEMANGEOL can cause breathing problems or make them worse. Get medical help right away if your child has wheezing or trouble breathing.

Cardiac failure. In certain patients with preexisting heart conditions, HEMANGEOL can worsen the heart’s ability to pump blood.

Increased risk of stroke. HEMANGEOL may increase the risk of stroke in children with certain blood vessel conditions (such as PHACE syndrome). Your healthcare provider may check for these conditions, especially in infants with large facial hemangiomas, before starting treatment.

Hypersensitivity. HEMANGEOL may make severe allergic reactions worse and may make it harder to treat these reactions with epinephrine (a medicine used in emergencies).

What are the most common side effects of HEMANGEOL?

The most common side effects include trouble sleeping, respiratory infections (such as colds or bronchitis), diarrhea, and vomiting.

Drug interactions

Tell your healthcare provider about all medicines your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Certain medicines may affect how HEMANGEOL works or increase the risk of side effects, including medicines that affect how the body processes propranolol or increase the risk of low blood sugar (such as corticosteroids).

You are encouraged to report negative side effects of prescription drugs by contacting Eton Pharmaceuticals, Inc. at 1-855-224-0233 or the U.S. Food and Drug Administration (FDA) at https://www.fda.gov/safety/medwatch or call 1-800-FDA-1088.

Please see

full Prescribing Information

for more information.

About
 
Eton
Pharmaceuticals

Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has ten commercial rare disease products: KHINDIVITM, INCRELEX®, ALKINDI SPRINKLE®, DESMODA™, GALZIN®, HEMANGEOL®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has four additional product candidates in late-stage development: Amglidia®, ET-700, ET-800 and ZENEO® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.

Investor Relations:

Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: [email protected]



Investor Notice: Medpace (NASDAQ:MEDP) may have Committed Securities Fraud after Cancellation Rates Disclosed – Contact BFA Law about the Pending Class Action

Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026

NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws.

If you invested in Medpace, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medpace-class-action-lawsuit.

Key Details of the Medpace ($MEDP) Class Action:

  • Lead Plaintiff Deadline: June 8, 2026
  • Alleged Misconduct: Securities fraud regarding Medpace’s alleged understatement of cancellation rates and overstatement of book-to-bill ratio.
  • Largest Alleged Stock Decline: February 9, 2026 – 15.9% Stock Drop
  • Court: U.S. District Court for the Southern District of Ohio
  • Action: Contact BFA Law to discuss your rights

Investors have until June 8, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Medpace common stock. The case is pending in the U.S. District Court for the Southern District of Ohio. It is captioned Durbin v. Medpace Holdings Inc., et al., No. 1:26-cv-00346.

Why is Medpace Being Sued For Securities Fraud?

Medpace is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries.

During the relevant period, Medpace allegedly misled investors concerning its book-to-bill ratio for 4Q 25. According to Medpace, “our award notifications were strong. Cancellations were down across the pipeline.” Medpace also discussed how cancellations were “very well behaved.”

As alleged, in truth, Medpace’s cancellations had increased causing its book-to-bill ratio to decline.

Why did Medpace’s Stock Drop?

On February 9, 2026, Medpace released its 4Q 2025 financial results, reporting that its book-to-bill ratio declined to 1.04 due to elevated cancellations.

This news caused the price of Medpace stock to drop nearly 16%, from $530.35 per share on February 9, 2026 to 446.05 per share on February 10, 2026.

BFA is also investigating recent reports that Medpace’s cancellations continued to increase and book-to-bill ratio continued to decline, reaching as low as 0.88 for 1Q 26. The company’s President, Jesse Geiger, also announced his intention to resign.
  
On this news, the price of the company’s stock declined roughly 23% during afternoon trading on April 23, 2026.

Click here for more information:

https://www.bfalaw.com/cases/medpace-class-action-lawsuit

.

What Can You Do?

If you invested in Medpace, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/medpace-class-action-lawsuit

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/medpace-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



Phreesia Sets Release Date for Fiscal First Quarter 2027 Results

Phreesia Sets Release Date for Fiscal First Quarter 2027 Results

ALL-REMOTE COMPANY/WILMINGTON, Del.–(BUSINESS WIRE)–
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2027 financial results after the close of market trading on Wednesday, May 27, 2026. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5PM Eastern Time on the same day.

To participate in the company’s live conference call and webcast, please dial (833) 461-5787, or (626) 884-3620 for international participants, using conference code number 953036497, or visit the “Events & Presentations” section of ir.phreesia.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

ABOUT PHREESIA

Phreesia is a trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 180 million patient visits in 2025—1 in 6 visits across the U.S. This scale allows Phreesia to make meaningful impact across the healthcare ecosystem. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives operational efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

Investors:

Balaji Gandhi

Phreesia, Inc.

[email protected]

(929) 506-4950

Media:

Nicole Gist

Phreesia, Inc.

[email protected]

(407) 760-6274

KEYWORDS: Delaware United States North America

INDUSTRY KEYWORDS: Health Technology Practice Management Health Technology Managed Care Software General Health

MEDIA:

Logo
Logo

AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results

Company to Participate in Upcoming Investor Conferences

MIAMI BEACH, Fla., May 01, 2026 (GLOBE NEWSWIRE) — AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2026 financial results before market open on Friday, May 8, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time.

The earnings conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13760143 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Technologies website at https://investors.airsculpt.com. A replay of the webcast will be available for approximately 90 days.

The Company also announced its participation in upcoming investor conferences.

On May 18, 2026, the Company will participate in the Wolfe Research Global Consumer Growth Conference being held virtually on May 18, 2026. Management will host a fireside chat presentation at 1:30 p.m. Eastern Time and hold virtual investor meetings throughout the day.

On May 19, 2026, the Company will participate in the 16th Annual LD Micro Invitational being held at the Luxe Sunset Blvd Hotel in Los Angeles on May 19, 2026. Management will host a presentation at 12:30 p.m. Pacific Time and hold investor meetings throughout the day.

The fireside chat presentations at both conferences will be available live and for replay on the Investor Relations page on the company’s website at https://investors.elitebodysculpture.com.

About AirSculpt

AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.

Investor Contact:

Allison Malkin
Partner, ICR Inc.
[email protected]



Atmus Filtration Technologies Reports First Quarter 2026 Results

Atmus Filtration Technologies Reports First Quarter 2026 Results

NASHVILLE, Tenn.–(BUSINESS WIRE)–
Atmus Filtration Technologies Inc. (Atmus; NYSE: ATMU), a global leader in filtration and media solutions, today reported financial results for its first quarter that ended March 31, 2026.

First Quarter Highlights

  • Net sales of $478 million

    • Power Solutions segment net sales of $439 million

    • Industrial Solutions segment net sales of $38 million

  • GAAP net income of $48 million

  • Diluted earnings per share of $0.59

  • Adjusted earnings per share of $0.69

  • Adjusted EBITDA of $95 million and Adjusted EBITDA margin of 19.8%

    • Power Solutions Segment Adjusted EBITDA of $86 million and Adjusted EBITDA margin of 19.6%

    • Industrial Solutions Segment Adjusted EBITDA of $8 million and Adjusted EBITDA margin of 21.9%

  • Cash provided by operating activities was $38 million

  • Adjusted free cash flow was $33 million

Atmus completed the acquisition of Koch Filter Corporation (“Koch Filter”) on January 7, 2026. The portfolio addition established Atmus’ Industrial Solutions segment, where Koch Filter results are reported. With the acquisition, Atmus reports on two business segments: Power Solutions, which serves global on- and off-highway equipment markets through its Fleetguard® brand; and Industrial Solutions, which addresses commercial and industrial HVAC applications, and high-growth end markets including data centers and power generation environments through its Koch Filter® brand.

2026 Outlook

The company is reaffirming guidance for the full year 2026 as follows:

  • Total company Net sales to be in the range of $1,945 million to $2,015 million

  • Power Solutions segment expected to be in the range of $1,790 million to $1,850 million

  • Industrial Solutions segment expected to be in the range of $155 million to $165 million

  • Adjusted EBITDA margin to be in the range of 19.5% to 20.5%

  • Adjusted earnings per share in the range of $2.75 to $3.00

During the quarter, Atmus repurchased $7 million of common stock under the $150 million share repurchase program authorized by the Board of Directors in July 2024. As of March 31, 2026, $62 million was remaining under the authorization. Additionally, Atmus paid a quarterly cash dividend of $0.055 per share of common stock.

“The Atmus team delivered strong financial results while simultaneously integrating Koch Filter to unlock growth for our Industrial Solutions business segment,” said Steph Disher, Chief Executive Officer of Atmus. “I continue to be inspired by our people’s ability to navigate uncertain markets and execute our four-pillar growth strategy to deliver long-term shareholder value.”

First Quarter Results

For the first quarter of 2026, Atmus posted net sales of $478 million, compared to $417 million in the first quarter of 2025, an increase of 14.6%. The increase in sales was primarily driven by the acquisition of Koch Filter, the favorable impacts of currency and increases in pricing, partially offset by lower volumes.

Gross margin was $137 million, compared to $111 million in the first quarter of 2025. Gross margin as a percent of net sales was 28.6% compared to 26.5% in the same period last year. The increase in Gross margin was primarily due to incremental margin from the acquisition of Koch Filter, increases in pricing, lower one-time costs associated with the separation of the business from Cummins Inc. and favorable impacts of currency, partially offset by higher logistics and duties costs, lower volumes and other manufacturing costs.

Adjusted EBITDA was $95 million, compared to $82 million in the first quarter of 2025. Adjusted EBITDA margin was 19.8% compared to 19.6% in the same period last year. Adjusted EBITDA in the first quarter of 2026 excludes $6 million of acquisition costs and $1 million of one-time integration costs associated with the acquisition of Koch Filter compared to the prior year quarter which excludes $9 million of one-time costs associated with the separation of the business from Cummins.

Net income was $48 million, or $0.59 of diluted earnings per share in the first quarter of 2026, compared to $45 million, or $0.54 of diluted earnings per share in the same period last year.

Adjusted earnings per share was $0.69 in the first quarter of 2026, compared to $0.63 of Adjusted earnings per share in the same period last year.

The effective tax rate for the first quarter of 2026 was 20.9% compared to 21.3% for the same period last year.

Cash provided by operating activities was $38 million in the first quarter of 2026, compared to cash provided by operating activities of $29 million in the first quarter of 2025.

Adjusted free cash flow was $33 million in the first quarter of 2026, compared to $20 million in the first quarter of 2025. Adjusted free cash flow in the first quarter of 2026 excludes $6 million of acquisition costs and $1 million of one-time integration costs associated with the acquisition of Koch Filter. The first quarter of 2025 excludes $4 million of one-time adjustments associated with the separation of the business from Cummins.

First Quarter 2026 Conference Call and Webcast

Atmus will host a conference call and webcast to discuss the company’s first quarter 2026 results on Friday, May 1, 2026, at 10:00 a.m. CT.

A live webcast and replay of the conference call can be accessed from the Atmus investor relations website at https://investors.atmus.com.

About Atmus Filtration Technologies Inc.

Atmus Filtration Technologies Inc. (Atmus; NYSE: ATMU) is a global leader in filtration and media solutions. With more than 65 years of innovation and engineering expertise to deliver high-performance filtration solutions, Atmus operates through two business segments: Power Solutions, which serves global on- and off-highway equipment markets through its trusted Fleetguard® brand; and Industrial Solutions, which addresses commercial and industrial HVAC applications, and high- growth end markets including data centers and power generation environments – through its dependable Koch Filter® brand. Headquartered in Nashville, Tenn., Atmus employs nearly 5,000 people worldwide who are committed to creating a better future by protecting what is important. Learn more at https://www.atmus.com.

Forward-looking disclosure statement

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, including, without limitation, those that are based on current expectations, estimates and projections about the industries in which we operate and management’s views, plans, objectives, projections, beliefs and assumptions. Forward-looking statements may be identified by the use of words such as “anticipates,” “expects,” “forecasts,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “could,” “should,” “may” or words of similar meaning. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding the outlook for our future business and financial performance, discussions of future operations, our strategy for growth and market position. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. If the underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, our actual outcomes, results and financial condition may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Risks and uncertainties include, but are not limited to, those reflected in Part I, Item 1A, “Risk Factors,” and elsewhere in our Annual Report on Form 10-K for our fiscal year ended December ‘31, 2025, in our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 and also as may be described from time to time in future reports we file with the Securities and Exchange Commission (SEC). You are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements made herein are made only as of the date hereof and we undertake no obligation to publicly update or to revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Non-GAAP measures

We use non-GAAP financial information and believe it is useful to investors as it provides additional information to facilitate comparisons of historical operating results, identify trends in our underlying operating results and provide additional insight and transparency on how we evaluate our business. We use non-GAAP financial measures to budget, make operating and strategic decisions and evaluate our performance. We have detailed the non-GAAP adjustments that we make in our non-GAAP definitions below. We believe the non-GAAP measures should always be considered along with the related U.S. GAAP financial measures. We have provided the reconciliations between the U.S. GAAP and non-GAAP financial measures and we also discuss our underlying U.S. GAAP results throughout our Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for our fiscal year ended December 31, 2025 and in our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026.

Our primary non-GAAP financial measures are listed below and reflect how we evaluate our current and prior-year operating results. As new events or circumstances arise, these definitions could change. When our definitions change, we provide the updated definitions and present the related non-GAAP historical results on a comparable basis.

  • “EBITDA” is defined as earnings or losses before interest expense, income taxes, depreciation and amortization and “EBITDA margin” is defined as EBITDA as a percent of Net sales. We believe EBITDA and EBITDA margin are useful measures of our operating performance as they assist investors and debt holders in comparing our performance on a consistent basis without regard to financing methods, capital structure, income taxes or depreciation and amortization methods, which can vary significantly depending upon many factors. Additionally, we believe these metrics are widely used by investors, securities analysts, ratings agencies and others in our industry in evaluating performance.

  • “Adjusted EBITDA” is defined as EBITDA after adding back certain one-time expenses, reflected in Cost of sales and Selling, general and administrative expenses, associated with becoming a standalone public company, transaction costs associated with the Koch Filter acquisition and costs related to the integration of Koch Filter and “Adjusted EBITDA margin” is defined as Adjusted EBITDA as a percent of Net sales. We believe Adjusted EBITDA and Adjusted EBITDA margin are useful measures of our operating performance as they allow investors and debt holders to compare our performance on a consistent basis without regard to one-time costs attributable to our becoming a standalone public company and costs associated with the acquisition and integration of Koch Filter.

  • “Adjusted earnings per share” is defined as diluted earnings per share (the most comparable U.S. GAAP financial measure) after adding back certain one-time expenses, reflected in Cost of sales and Selling, general and administrative expenses, associated with becoming a standalone public company, transaction costs associated with the Koch Filter acquisition, costs related to the integration of Koch Filter and amortization of the intangible assets acquired in the Koch Filter acquisition less the related tax impact of the same one-time expenses, acquisition and integration costs and amortization expense. We believe Adjusted earnings per share provides improved comparability of underlying operating results.

  • “Free cash flow” is defined as cash flows provided by (used for) operating activities less capital expenditures and “Adjusted free cash flow” is defined as Free cash flow after adding back certain one-time items associated with becoming a standalone public company, transaction costs associated with the Koch Filter acquisition and costs related to the integration of Koch Filter. We believe Free cash flow and Adjusted free cash flow are useful metrics used by management and investors to analyze our ability to service and repay debt and return value to shareholders.

The metrics defined above are not in accordance with, or alternatives for, U.S. GAAP financial measures and may not be consistent with measures used by other companies. It should be considered supplemental data; however, the amounts included in the EBITDA, EBITDA margin, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted earnings per share, Free cash flow and Adjusted free cash flow calculations are derived from amounts included in the consolidated statements of net income and cash flows.

We do not consider our non-GAAP financial measures as superior to, or a substitute for, the equivalent measures calculated and presented in accordance with GAAP. Some of the limitations are: such measures do not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments; such measures do not reflect changes in, or cash requirements for, our working capital needs; such measures do not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our debt; although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and such measures do not reflect any cash requirements for such replacements; and other companies in our industry may calculate such measures differently than we do, limiting their usefulness as comparative measures. To properly and prudently evaluate our business, we encourage you to review the unaudited condensed consolidated financial statements included in our SEC filings and not rely on a single financial measure to evaluate our business.

ATMUS FILTRATION TECHNOLOGIES INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME

(in millions of U.S. dollars, except per share data)

(Unaudited)

 

For the Three Months Ended March 31,

 

 

2026

 

 

 

2025

 

NET SALES(a)

$

477.5

 

 

$

416.5

 

Cost of sales

 

340.7

 

 

 

306.0

 

GROSS MARGIN

 

136.8

 

 

 

110.5

 

OPERATING EXPENSES AND INCOME

 

 

 

Selling, general and administrative expenses

 

51.0

 

 

 

45.9

 

Research, development and engineering expenses

 

8.1

 

 

 

9.1

 

Equity, royalty and interest income from investees

 

7.6

 

 

 

9.2

 

Intangible asset amortization

 

2.9

 

 

 

 

Other operating expense (income), net

 

6.1

 

 

 

(0.2

)

OPERATING INCOME

 

76.3

 

 

 

64.9

 

Interest expense

 

14.1

 

 

 

8.4

 

Other (expense) income, net

 

(1.0

)

 

 

0.3

 

INCOME BEFORE INCOME TAXES

 

61.2

 

 

 

56.8

 

Income tax expense

 

12.8

 

 

 

12.1

 

NET INCOME

$

48.4

 

 

$

44.7

 

PER SHARE DATA:

 

 

 

Weighted-average shares for basic EPS

 

81.6

 

 

 

82.8

 

Weighted-average shares for diluted EPS

 

82.0

 

 

 

83.2

 

 

 

 

 

Basic earnings per share

$

0.59

 

 

$

0.54

 

Diluted earnings per share

$

0.59

 

 

$

0.54

 

(a)

Includes sales to related parties of $13.8 million for the three months ended March 31, 2026, compared with $13.7 million for the three months ended March 31, 2025.

ATMUS FILTRATION TECHNOLOGIES INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions of U.S. dollars, except share data)

(Unaudited)

 

March 31,

2026

 

December 31,

2025

ASSETS

 

 

 

Cash and cash equivalents

$

209.6

 

 

$

236.4

 

Trade and other receivables, net

 

355.6

 

 

 

320.1

 

Inventories

 

298.7

 

 

 

282.3

 

Prepaid expenses and other current assets

 

47.2

 

 

 

53.6

 

Total current assets

 

911.1

 

 

 

892.4

 

Property, plant and equipment, net

 

212.6

 

 

 

197.1

 

Investments and advances related to equity method investees

 

92.1

 

 

 

89.2

 

Goodwill

 

303.9

 

 

 

84.7

 

Intangible assets, net

 

212.1

 

 

 

 

Other assets

 

110.0

 

 

 

87.3

 

TOTAL ASSETS

$

1,841.8

 

 

$

1,350.7

 

LIABILITIES

 

 

 

Accounts payable

$

234.1

 

 

$

201.9

 

Accrued compensation, benefits and retirement costs

 

25.2

 

 

 

37.9

 

Current portion of accrued product warranty

 

3.7

 

 

 

5.4

 

Current maturities of long-term debt

 

 

 

 

30.0

 

Other accrued expenses

 

97.6

 

 

 

93.0

 

Total current liabilities

 

360.6

 

 

 

368.2

 

Long-term debt

 

998.1

 

 

 

540.0

 

Accrued product warranty

 

5.6

 

 

 

8.0

 

Other liabilities

 

74.0

 

 

 

56.0

 

TOTAL LIABILITIES

 

1,438.3

 

 

 

972.2

 

Commitments and contingencies (Note 9)

 

 

 

EQUITY

 

 

 

Common stock, $0.0001 par value (2,000,000,000 shares authorized, 83,782,408 and 83,504,555 shares issued at March 31, 2026 and December 31, 2025, respectively)

 

 

 

 

 

Additional paid-in capital

 

65.1

 

 

 

72.7

 

Retained earnings

 

498.6

 

 

 

454.6

 

Accumulated other comprehensive loss

 

(72.2

)

 

 

(68.1

)

Treasury stock, at cost (2,109,980 shares at March 31, 2026 and 1,995,964 shares at December 31, 2025)

 

(88.0

)

 

 

(80.7

)

TOTAL EQUITY

 

403.5

 

 

 

378.5

 

TOTAL LIABILITIES AND EQUITY

$

1,841.8

 

 

$

1,350.7

 

ATMUS FILTRATION TECHNOLOGIES INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions of U.S. dollars)

(Unaudited)

 

For the Three Months Ended March 31,

 

 

2026

 

 

 

2025

 

CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

 

 

 

Net income

$

48.4

 

 

$

44.7

 

Adjustments to reconcile net income to operating cash flows:

 

 

 

Depreciation and amortization

 

11.8

 

 

 

7.2

 

Deferred income taxes

 

1.5

 

 

 

(0.1

)

Equity in income of investees, net of dividends

 

(6.0

)

 

 

(1.9

)

Share-based compensation

 

3.4

 

 

 

2.3

 

Foreign currency remeasurement and transaction exposure

 

(3.1

)

 

 

(0.5

)

Changes in current assets and liabilities:

 

 

 

Trade and other receivables

 

(16.9

)

 

 

(24.9

)

Inventories

 

(4.3

)

 

 

(1.1

)

Prepaid expenses and other current assets

 

7.0

 

 

 

3.4

 

Accounts payable

 

6.8

 

 

 

22.5

 

Other accrued expenses

 

(15.8

)

 

 

(22.0

)

Changes in other liabilities

 

(5.3

)

 

 

0.2

 

Other, net

 

10.6

 

 

 

(1.1

)

Net cash provided by operating activities

 

38.1

 

 

 

28.7

 

CASH USED IN INVESTING ACTIVITIES

 

 

 

Capital expenditures

 

(12.6

)

 

 

(12.4

)

Acquisitions, net of cash acquired

 

(455.3

)

 

 

 

Net cash used in investing activities

 

(467.9

)

 

 

(12.4

)

CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

 

 

 

Long-term debt proceeds, net of financing costs paid

 

995.6

 

 

 

 

Payments on long-term debt

 

(570.0

)

 

 

(3.8

)

Repurchases of Common stock

 

(7.3

)

 

 

(10.0

)

Dividends paid

 

(4.4

)

 

 

(4.1

)

Withholding taxes paid on stock-based compensation

 

(11.0

)

 

 

 

Other, net

 

(0.3

)

 

 

 

Net cash provided by (used in) financing activities

 

402.6

 

 

 

(17.9

)

Effect of exchange rate changes on cash and cash equivalents

 

0.4

 

 

 

0.6

 

Net decrease in cash and cash equivalents

 

(26.8

)

 

 

(1.0

)

Cash and cash equivalents at beginning of period

 

236.4

 

 

 

184.3

 

CASH AND CASH EQUIVALENTS AT END OF PERIOD

$

209.6

 

 

$

183.3

 

ATMUS FILTRATION TECHNOLOGIES INC. AND SUBSIDIARIES

EARNINGS PER SHARE – RECONCILIATION

(in millions of U.S. dollars, except per share data)

(Unaudited)

 

For the Three Months Ended March 31,

 

 

2026

 

 

2025

Net income

$

48.4

 

$

44.7

Weighted-average shares for basic EPS

 

81.6

 

 

82.8

Plus incremental shares from assumed conversions of long-term

incentive plan shares

 

0.4

 

 

0.4

Weighted-average shares for diluted EPS

 

82.0

 

 

83.2

Basic earnings per share

$

0.59

 

$

0.54

Diluted earnings per share

$

0.59

 

$

0.54

ATMUS FILTRATION TECHNOLOGIES INC. AND SUBSIDIARIES

NET INCOME TO EBITDA AND ADJUSTED EBITDA – RECONCILIATION

(in millions of U.S. dollars)

(Unaudited)

 

For the Three Months Ended March 31,

 

 

2026

 

 

 

2025

 

NET INCOME

$

48.4

 

 

$

44.7

 

Plus:

 

 

 

Interest expense

 

14.1

 

 

 

8.4

 

Income tax expense

 

12.8

 

 

 

12.1

 

Depreciation and amortization

 

11.8

 

 

 

7.2

 

EBITDA (non-GAAP)

$

87.1

 

 

$

72.4

 

Plus:

 

 

 

Acquisition costs(a)

$

6.3

 

 

$

 

One-time integration costs(a)

 

1.1

 

 

 

 

One-time separation costs(b)

 

 

 

 

9.3

 

Adjusted EBITDA (non-GAAP)

$

94.5

 

 

$

81.7

 

Net sales

$

477.5

 

 

$

416.5

 

Net income margin

 

10.1

%

 

 

10.7

%

EBITDA margin (non-GAAP)

 

18.2

%

 

 

17.4

%

Adjusted EBITDA margin (non-GAAP)

 

19.8

%

 

 

19.6

%

(a)

Primarily comprised of transaction costs associated to the Koch Filter acquisition and other Information Technology, Human Resources and manufacturing costs related to the integration of Koch Filter.

(b)

Primarily comprised of one-time expenses related to Information Technology, warehousing, manufacturing and Human Resources separation costs.

ATMUS FILTRATION TECHNOLOGIES INC. AND SUBSIDIARIES

DILUTED EARNINGS PER SHARE TO ADJUSTED EARNINGS PER SHARE – RECONCILIATION

(per share)

(Unaudited)

 

For the Three Months Ended March 31,

 

 

2026

 

 

2025

Diluted earnings per share

$

0.59

 

$

0.54

Plus:

 

 

 

Acquisition costs(a)

$

0.08

 

$

One-time integration costs(a)

 

0.01

 

 

One-time separation costs(b)

 

 

 

0.11

Intangible asset amortization(c)

 

0.04

 

 

Less:

 

 

 

Tax impact of acquisition costs(a)

$

0.02

 

$

Tax impact of one-time integration costs(a)

 

 

 

Tax impact of one-time separation costs(b)

 

 

 

0.02

Tax impact of intangible asset amortization(c)

 

0.01

 

 

Adjusted earnings per share

$

0.69

 

$

0.63

(a)

Primarily comprised of transaction costs associated to the Koch Filter acquisition and other Information Technology, Human Resources and manufacturing costs related to the integration of Koch Filter. The tax impact of acquisition costs and integration costs for the three months ended March 31, 2026 were $1.3 million and $0.2 million, respectively.

(b)

Primarily comprised of one-time expenses related to Information Technology, warehousing, manufacturing and Human Resources separation costs and the related tax impact of those expenses. The tax impact of one-time separation costs for the three months ended March 31, 2025 were $2.0 million.

(c)

Amortization expense of the intangible assets acquired in the Koch Filter acquisition was $2.9 million for the three months ended March 31, 2026. The tax impact of the amortization expense for the three months ended March 31, 2026 was $0.6 million.

ATMUS FILTRATION TECHNOLOGIES INC. AND SUBSIDIARIES

CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW AND

ADJUSTED FREE CASH FLOW – RECONCILIATION

(in millions of U.S. dollars)

(Unaudited)

 

For the Three Months Ended March 31,

 

 

2026

 

 

2025

Cash provided by operating activities

$

38.1

 

$

28.7

Less:

 

 

 

Capital expenditures

 

12.6

 

 

12.4

Free cash flow (non-GAAP)

$

25.5

 

$

16.3

Plus:

 

 

 

Acquisition costs

$

6.3

 

$

One-time integration costs

 

1.1

 

 

One-time separation capital expenditures

 

 

 

3.5

Adjusted free cash flow (non-GAAP)

$

32.9

 

$

19.8

ATMUS FILTRATION TECHNOLOGIES INC. AND SUBSIDIARIES

SUMMARIZED SEGMENT OPERATING RESULTS AND RECONCILIATION TO

INCOME BEFORE INCOME TAXES

(in millions of U.S. dollars)

(Unaudited)

 

For the Three Months Ended March 31, 2026

 

Power

Solutions

 

Industrial Solutions

 

Total

External Sales

$

439.1

 

 

$

38.4

 

 

$

477.5

 

 

 

 

 

 

Cost of sales

 

312.7

 

 

 

27.5

 

 

 

Selling, general and administrative expenses

 

47.2

 

 

 

3.2

 

 

 

Research, development and engineering expenses

 

8.1

 

 

 

 

 

 

Equity, royalty and interest income from investees

 

7.6

 

 

 

 

 

 

Other expense (income) (a)

 

0.8

 

 

 

 

 

 

Add back: Depreciation and amortization (b)

 

8.2

 

 

 

0.7

 

 

 

Segment Adjusted EBITDA

$

86.1

 

 

$

8.4

 

 

$

94.5

 

 

 

 

 

 

Segment Adjusted EBITDA Margin

 

19.6

%

 

 

21.9

%

 

 

 

 

 

 

 

 

Reconciliation to Income before income taxes:

 

 

 

 

 

Corporate expenses (c)

 

 

 

 

$

7.4

Interest expenses

 

 

 

 

 

14.1

Depreciation and amortization

 

 

 

 

 

11.8

Income before income taxes

 

 

 

 

$

61.2

(a)

 

Other expense (income) includes Other operating expense (income), net and Other (expense) income, net from our Condensed Consolidated Statement of Net Income.

(b)

 

Depreciation and amortization are not considered significant segment expenses but are presented here to reconcile to Segment Adjusted EBITDA, the measure used by our CODM. The amount of depreciation and amortization disclosed by reportable segment is included within the cost of sales and selling, general and administrative expenses.

(c)

 

Corporate expenses include $7.4 million of costs associated with the acquisition and subsequent integration of Koch Filter.

 

For the Three Months Ended March 31, 2025

 

Power Solutions

 

Total

External Sales

$

416.5

 

 

$

416.5

 

 

 

 

Cost of sales

 

299.2

 

 

 

Selling, general and administrative expenses

 

43.4

 

 

 

Research, development and engineering expenses

 

9.1

 

 

 

Equity, royalty and interest income from investees

 

9.2

 

 

 

Other (income) expense (a)

 

(0.5

)

 

 

Add back: Depreciation and amortization (b)

 

7.2

 

 

 

Segment Adjusted EBITDA

$

81.7

 

 

$

81.7

 

 

 

 

Segment Adjusted EBITDA Margin

 

19.6

%

 

 

 

 

 

 

Reconciliation to Income before income taxes:

 

 

 

Corporate expenses (c)

 

 

$

9.3

Interest expenses

 

 

 

8.4

Depreciation and amortization

 

 

 

7.2

Income before income taxes

 

 

$

56.8

(a)

 

Other (income) expense includes Other operating expense (income), net and Other (expense) income, net from our Condensed Consolidated Statements of Net Income.

(b)

 

Depreciation and amortization are not considered significant segment expenses but are presented here to reconcile to Segment Adjusted EBITDA, the measure used by our CODM. The amount of depreciation and amortization disclosed by reportable segment is included within the cost of sales and selling, general and administrative expenses.

(c)

 

Corporate expenses include $9.3 million of one-time separation costs.

 

Media Contacts

Investor relations:

Todd Chirillo

[email protected]

Media relations:

Jayme Owen

[email protected]

KEYWORDS: Tennessee United States North America

INDUSTRY KEYWORDS: HVAC Engineering Other Manufacturing Manufacturing

MEDIA:

Logo
Logo

GrafTech Reports First Quarter 2026 Results

GrafTech Reports First Quarter 2026 Results

Delivering Strong Sales Volume Growth

Reaffirming Full-Year Volume and Cost Expectations

Executing Pricing Actions and Other Strategic Initiatives to Support Long-term Value

BROOKLYN HEIGHTS, Ohio–(BUSINESS WIRE)–
GrafTech International Ltd. (NYSE: EAF) (“GrafTech,” the “Company,” “we,” or “our”) today announced its unaudited financial results for the quarter ended March 31, 2026.

First Quarter 2026 Summary

  • Sales volume of 28.1 thousand MT, an increase of 14% year-over-year

  • Net sales of $125 million, an increase of 12% year-over-year

  • Net loss of $43 million, or $1.66 per share(1)
  • Adjusted EBITDA(2) of negative $14 million

  • Net cash used in operating activities of $15 million

  • Adjusted free cash flow(2) of negative $27 million

  • Total liquidity of $329 million as of March 31, 2026

CEO Comments

“We delivered 14% year-over-year sales volume growth in the first quarter and remain on track to meet our full-year volume expectation,” said Timothy Flanagan, Chief Executive Officer and President. “However, supply-side imbalance, driven by overcapacity that has been built in both China and India, translates into a current pricing environment that remains unsustainably weak. Our focus on commercial execution and disciplined cost management, combined with our $329 million liquidity position, allows us to maintain stability while we take actions to address these conditions.”

“We are taking decisive steps to restore more sustainable market dynamics and support the long-term viability of our business and our industry,” continued Mr. Flanagan. “These include implementing price increases on uncommitted volume and actively supporting trade cases in key jurisdictions. We believe these actions are necessary to correct market imbalances. We remain committed to providing reliable supply to our customers while improving our financial performance and delivering long-term shareholder value.”

First Quarter 2026 Financial Performance

(dollars in thousands, except per share amounts)

 

 

Q1 2026

Q4 2025

Q1 2025

Net sales

$

125,101

 

$

116,457

 

$

111,839

 

Net loss

$

(43,277

)

$

(65,116

)

$

(39,351

)

Loss per share(1)

$

(1.66

)

$

(2.50

)

$

(1.52

)

Net cash used in operating activities

$

(14,934

)

$

(20,894

)

$

(32,186

)

 

 

 

 

Adjusted net loss(2)

$

(53,527

)

$

(63,886

)

$

(34,155

)

Adjusted loss per share(1)(2)

$

(2.05

)

$

(2.45

)

$

(1.32

)

Adjusted EBITDA(2)

$

(13,550

)

$

(21,900

)

$

(3,672

)

Adjusted free cash flow(2)

$

(27,079

)

$

(39,265

)

$

(40,274

)

Net sales for the first quarter of 2026 were $125 million, an increase of 12% compared to $112 million for the first quarter of 2025, reflecting higher sales volume partially offset by a year-over-year decrease in our weighted-average realized price.

Net loss for the first quarter of 2026 was $43 million, or $1.66 per share, compared to a net loss of $39 million, or $1.52 per share, for the first quarter of 2025. Adjusted EBITDA(2) was negative $14 million for the first quarter of 2026, compared to adjusted EBITDA(2) of negative $4 million for the first quarter of 2025, with the year-over-year change primarily reflecting the decline in the weighted-average realized price.

For the first quarter of 2026, net cash used in operating activities was $15 million and adjusted free cash flow(2) was negative $27 million, compared to net cash used in operating activities of $32 million and adjusted free cash flow(2) of negative $40 million for the first quarter of 2025. The year-over-year improvement primarily reflected changes in working capital, including a planned inventory build in the first quarter of 2025.

Operational and Commercial Update

Key Operating Metrics

 

 

 

 

 

 

 

(in thousands, except percentages)

Q1 2026

Q4 2025

Q1 2025

Sales volume (MT)

28.1

 

27.1

 

24.7

 

Production volume (MT)

29.4

 

27.8

 

28.5

 

Production capacity (MT)(3)(4)

45.0

 

46.0

 

45.0

 

Capacity utilization(5)

65

%

60

%

63

%

Sales volume for the first quarter of 2026 was 28.1 thousand MT, an increase of 14% compared to the first quarter of 2025. For the first quarter of 2026, our weighted-average realized price was approximately $3,900 per MT, representing a 5% decrease compared to the first quarter of 2025. The year-over-year pricing decline reflected persistent competitive pressures across most of our principal commercial regions, partially mitigated by favorable mix as we achieved 37% sales volume growth in the United States, which remains the strongest region for graphite electrode pricing.

Production volume was 29.4 thousand MT for the first quarter of 2026, resulting in a capacity utilization rate of 65% for the quarter.

Capital Structure and Liquidity

As of March 31, 2026, we had total liquidity of $328.7 million, consisting of cash and cash equivalents of $120.2 million, $108.5 million of availability under our revolving credit facility and $100.0 million of availability under our senior secured first lien delayed draw term loans, which continues to support our ability to manage through the near-term, industry-wide challenges. As of March 31, 2026, we had gross debt(6) of $1,125 million, with substantially no maturities until December 2029, and net debt(7) of approximately $1,005 million.

Outlook

Demand for graphite electrodes is expected to improve modestly in 2026, supported by stable-to-improving steel production trends outside of China. While steel market conditions remain mixed, in the United States, demand has been relatively stable and is expected to increase modestly, with steel production further supported by favorable trade policies. In Europe, steel industry conditions have been more challenged, though there are early signs of recovery, including expected demand growth and recently approved increases in trade protections. For GrafTech, we continue to expect a 5–10% year-over-year increase in graphite electrode sales volume for 2026, with more than 85% of our anticipated volume already committed in our order book.

While volume trends are stable, current industry-wide pricing levels do not reflect the indispensable nature of graphite electrodes for electric arc furcnace steelmaking. As a result, we are taking deliberate actions to restore more sustainable pricing and improve our profitability. These include implementing price increases of $600 to $1,200 per metric ton on uncommitted volume, actively supporting graphite electrode trade cases in key jurisdictions, including the United States and Brazil, continuing to optimize our order book by prioritizing higher-value regions and foregoing volume opportunities where margins are unacceptably low.

On costs, geopolitical developments continue to impact key input costs, including oil-based raw materials, energy and logistics. In response, we are expanding initiatives to improve our cost structure, including enhancing production efficiency and optimizing production schedules. Factoring all of this in, we continue to expect a low single-digit percentage-point decline in our cash cost of goods sold per MT for 2026 compared to 2025.

We are also maintaining disciplined capital and working capital management. For 2026, we expect a modest increase in working capital for the full year to support higher volume. We continue to anticipate our full-year capital expenditures will be approximately $35 million, consistent with maintaining our assets at current utilization levels.

Longer term, we remain confident in the structural drivers of demand growth for graphite electrodes. The ongoing shift toward electric arc furnace steelmaking and growing demand for petroleum needle coke in battery applications are expected to support sustained industry growth. We believe the actions we are taking, combined with our vertical integration and a leading competitive position, will enable GrafTech to benefit as market conditions normalize.

Conference Call Information

In connection with this earnings release, you are invited to listen to our earnings call being held on May 1, 2026 at 10:00 a.m. (EDT). The webcast and accompanying slide presentation will be available on our investor relations website at: http://ir.graftech.com. The earnings call dial-in number is +1 (800) 715-9871 toll-free in the United States or +1 (646) 307-1963 for international calls, conference ID: 2242863. Archived replays of the conference call and webcast will be made available on our investor relations website at: http://ir.graftech.com. GrafTech also makes its complete financial reports that have been filed with the Securities and Exchange Commission (“SEC”) and other information available at: www.GrafTech.com. The information on our website is not part of this release or any report we file with or furnish to the SEC.

About GrafTech

GrafTech International Ltd. is a leading manufacturer of high-quality graphite electrode products essential to the production of electric arc furnace steel and other ferrous and non-ferrous metals. We believe the Company has a competitive portfolio of low-cost, ultra-high power graphite electrode manufacturing facilities, with some of the highest capacity facilities in the world. We are the only large-scale graphite electrode producer that is substantially vertically integrated into petroleum needle coke, our key raw material for graphite electrode manufacturing. This unique position provides us with a number of competitive advantages.

_____________

(1)

Loss per share represents diluted loss per share. Adjusted loss per share represents diluted adjusted loss per share. All share and per share data presented have been retroactively adjusted for all periods to reflect a reverse stock split of our common stock at a ratio of 1-for-10, which became effective on August 29, 2025.

(2)

A non-GAAP financial measure, see below for more information and reconciliations to the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

(3)

Production capacity reflects expected maximum production volume during the period depending on product mix and expected maintenance outage. Actual production may vary.

(4)

Includes graphite electrode facilities in Calais, France; Monterrey, Mexico; and Pamplona, Spain.

(5)

Capacity utilization reflects production volume as a percentage of production capacity.

(6)

Gross debt reflects the notional value of our outstanding debt and excludes unamortized debt discount and issuance costs.

(7)

A non-GAAP financial measure, net debt is calculated as gross debt minus cash and cash equivalents (March 31, 2026 gross debt of $1,125 million less March 31, 2026 cash and cash equivalents of $120 million).

Cautionary Note Regarding Forward-Looking Statements

This press release and related discussions may contain forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our current views with respect to, among other things, financial projections, plans and objectives of management for future operations, future economic performance and short-term and long-term liquidity. Examples of forward-looking statements include, among others, statements we make regarding future estimated volume, pricing and revenue, and anticipated levels of capital expenditures and cost of goods sold. You can identify these forward-looking statements by the use of forward-looking words such as “will,” “may,” “plan,” “estimate,” “project,” “believe,” “anticipate,” “expect,” “foresee,” “intend,” “should,” “would,” “could,” “target,” “goal,” “continue to,” “positioned to,” “are confident,” or the negative versions of those words or other comparable words. Any forward-looking statements contained in this press release are based upon our historical performance and on our current plans, estimates and expectations considering information currently available to us. The inclusion of this forward-looking information should not be regarded as a representation by us that the future plans, estimates, or expectations contemplated by us will be achieved. Our expectations and targets are not predictions of actual performance and historically our performance has deviated, often significantly, from our expectations and targets. These forward-looking statements are subject to various risks and uncertainties and assumptions relating to our operations, financial results, financial condition, business, prospects, growth strategy and liquidity. Accordingly, there are or will be important factors that could cause our actual results to differ materially from those indicated in these statements. We believe that these factors include, but are not limited to: our dependence on the global steel industry generally and the electric arc furnace steel industry in particular; the cyclical nature of our business and the selling prices of our products, which may remain at depressed levels or further decline in the future, and may continue to experience prolonged periods of reduced profitability and net losses or adversely impact liquidity; the sensitivity of our business and operating results to economic conditions, including any recession, and the possibility others may not be able to fulfill their obligations to us in a timely fashion or at all; the possibility that we may be unable to implement our business strategies in an effective manner, including our ability to effectively increase or maintain existing prices and shift sales to regions with higher average selling prices; continued overcapacity of the global graphite electrode industry, which may further adversely affect graphite electrode prices; the competitiveness of the graphite electrode industry; our dependence on the cost and availability of manufacturing inputs, including raw materials, such as decant oil, petroleum needle coke, energy and freight, and disruptions in availability for such inputs; our primary reliance on one facility in Monterrey, Mexico for the manufacturing of connecting pins; the cost of electric power and natural gas, particularly in Europe; our manufacturing operations are subject to hazards; the legal, compliance, economic, social and political risks associated with our substantial operations in multiple countries; the possibility that fluctuation of foreign currency exchange rates could materially harm our financial results; the possibility that our results of operations could further deteriorate if our manufacturing operations were substantially disrupted for an extended period, including as a result of equipment failure, climate change, regulatory issues, natural disasters, public health crises, such as a global pandemic, political crises or other catastrophic events; the risks and uncertainties associated with litigation, arbitration, and like disputes, including disputes related to contractual commitments; our dependence on third parties for certain construction, maintenance, engineering, transportation, warehousing and logistics services; the possibility that we are subject to information technology systems failures, cybersecurity incidents, network disruptions and breaches of data security, including with respect to our third-party suppliers and business partners; the possibility that we are unable to recruit or retain key management and plant operating personnel or successfully negotiate with the representatives of our employees, including labor unions; the sensitivity of long-lived assets on our balance sheet to changes in the market; our dependence on protecting our intellectual property and the possibility that third parties may claim that our products or processes infringe their intellectual property rights; the impact of inflation and our ability to mitigate the effect on our costs; the impact of macroeconomic and geopolitical events on our business, results of operations, financial condition and cash flows, and the disruptions and inefficiencies in our supply chain that may occur as a result of such events; uncertain shifts in domestic and foreign trade policies and the possibility that the imposition of current, new or increased custom duties and tariffs and trade barriers in the countries in which we, our customers and our suppliers operate could adversely affect our ability to compete, operations, results of operations and financial condition; risks associated with strategic transactions, including acquisitions, divestitures, joint ventures, equity investments, and debt issuances, that could adversely affect our business, operating results and financial condition; the possibility that our indebtedness could limit our financial and operating activities or that our cash flows may not be sufficient to service our indebtedness; any current or future borrowings may subject us to interest rate risk; risks and uncertainties associated with our ability to access the capital and credit markets could adversely affect our results of operations, cash flows and financial condition; the possibility that disruptions in the capital and credit markets could adversely affect our customers and suppliers; the possibility that restrictive covenants in our financing agreements could restrict or limit our operations; and changes in health, safety and environmental regulations applicable to our manufacturing operations and facilities.

These factors should not be construed as exhaustive and should be read in conjunction with the Risk Factors and other cautionary statements that are included in our Annual Report on Form 10-K and other filings with the SEC. The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Except as required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. You should specifically consider the factors identified in this press release and in our Annual Report on Form 10-K that could cause actual results to differ before making an investment decision to purchase our common stock. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us.

Non‑GAAP Financial Measures

In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA, adjusted EBITDA, adjusted net loss, adjusted loss per share, free cash flow, adjusted free cash flow, net debt and cash cost of goods sold per MT are non-GAAP financial measures.

We define EBITDA, a non‑GAAP financial measure, as net loss plus interest expense, minus interest income, plus income taxes and depreciation and amortization. We define adjusted EBITDA, a non-GAAP financial measure, as EBITDA adjusted by any pension and other post-employment benefit (“OPEB”) expenses, non‑cash gains or losses from foreign currency remeasurement of non‑operating assets and liabilities in our foreign subsidiaries where the functional currency is the U.S. dollar, stock-based compensation expense, gains on asset sales and Tax Receivable Agreement adjustments. Adjusted EBITDA is the primary metric used by our management and our Board of Directors to establish budgets and operational goals for managing our business and evaluating our performance.

We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period‑to‑period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. In addition, we believe adjusted EBITDA and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt‑service capabilities.

We define adjusted net loss, a non‑GAAP financial measure, as net loss, excluding the items used to calculate adjusted EBITDA and further excluding debt modification costs, less the tax effect of those adjustments and non-cash income tax expense related to the establishment of a deferred tax valuation allowance. We define adjusted loss per share, a non‑GAAP financial measure, as adjusted net loss divided by the weighted average diluted common shares outstanding during the period. We believe adjusted net loss and adjusted loss per share are useful to present to investors because we believe that they assist investors’ understanding of the underlying operational profitability of the Company.

We define free cash flow, a non-GAAP financial measure, as net cash provided by or used in operating activities less capital expenditures. We define adjusted free cash flow, a non-GAAP financial measure, as free cash flow adjusted by payments made for debt modification costs. We use free cash flow and adjusted free cash flow as critical measures in the evaluation of liquidity in conjunction with related GAAP amounts. We also use these measures when considering available cash, including for decision-making purposes related to dividends and discretionary investments. Further, these measures help management, the Board of Directors, and investors evaluate the Company’s ability to generate liquidity from operating activities.

We define net debt, a non-GAAP financial measure, as gross debt minus cash and cash equivalents. We believe this is an important measure as it is more representative of our financial position.

We define cash cost of goods sold per MT, a non-GAAP financial measure, as cost of goods sold less depreciation and amortization and less cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes, with this total divided by our sales volume measured in MT. We believe this is an important measure as it is used by our management and Board of Directors to evaluate our costs on a per MT basis.

In evaluating these non-GAAP financial measures, you should be aware that in the future, we may incur expenses similar to the adjustments in the reconciliations presented below. Our presentations of these non-GAAP financial measures should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non‑recurring items. When evaluating our performance, you should consider these non-GAAP financial measures alongside other measures of financial performance and liquidity, including our net loss, loss per share, cash flow from operating activities, cost of goods sold and other GAAP measures.

 

GRAFTECH INTERNATIONAL LTD. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share data)

(Unaudited)

 

 

March 31,

2026

 

December 31,

2025

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

120,244

 

 

$

138,427

 

Accounts receivable, net of allowance for doubtful accounts of

$4,216 as of March 31, 2026 and $3,271 as of December 31, 2025

 

79,912

 

 

 

73,235

 

Inventories

 

223,115

 

 

 

224,692

 

Prepaid and other current assets

 

42,926

 

 

 

48,180

 

Total current assets

 

466,197

 

 

 

484,534

 

Property, plant and equipment

 

985,093

 

 

 

986,946

 

Less: accumulated depreciation

 

507,044

 

 

 

497,016

 

Net property, plant and equipment

 

478,049

 

 

 

489,930

 

Deferred income taxes

 

9,437

 

 

 

9,318

 

Other assets

 

43,518

 

 

 

45,007

 

Total assets

$

997,201

 

 

$

1,028,789

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

68,709

 

 

$

67,017

 

Accrued income and other taxes

 

8,914

 

 

 

8,047

 

Other accrued liabilities

 

40,955

 

 

 

48,363

 

Interest payable

 

21,507

 

 

 

4,764

 

Total current liabilities

 

140,085

 

 

 

128,191

 

 

 

 

 

Long-term debt

 

1,096,654

 

 

 

1,094,706

 

Other long-term obligations

 

39,848

 

 

 

40,388

 

Deferred income taxes

 

25,047

 

 

 

25,132

 

Stockholders’ deficit:

 

 

 

Preferred stock, par value $0.01, 30,000,000 shares authorized, none issued

 

 

 

 

 

Common stock, par value $0.01, 300,000,000 shares authorized, 26,047,835 and 25,820,110 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

 

2,584

 

 

 

2,582

 

Additional paid-in capital

 

761,409

 

 

 

759,710

 

Accumulated other comprehensive loss

 

(12,000

)

 

 

(8,972

)

Accumulated deficit

 

(1,056,426

)

 

 

(1,012,948

)

Total stockholders’ deficit

 

(304,433

)

 

 

(259,628

)

Total liabilities and stockholders’ deficit

$

997,201

 

 

$

1,028,789

 

GRAFTECH INTERNATIONAL LTD. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Dollars in thousands, except per share data)

(Unaudited)

 

 

Three Months Ended

March 31,

 

 

2026

 

 

 

2025

 

 

 

 

 

Net sales

$

125,101

 

 

$

111,839

 

Cost of goods sold

 

134,833

 

 

 

110,765

 

Lower of cost or market inventory valuation adjustment

 

5,258

 

 

 

2,783

 

Gross loss

 

(14,990

)

 

 

(1,709

)

Research and development

 

1,443

 

 

 

1,879

 

Selling and administrative expenses

 

14,228

 

 

 

14,622

 

Operating loss

 

(30,661

)

 

 

(18,210

)

 

 

 

 

Other (income) expense, net

 

(12,048

)

 

 

447

 

Interest expense

 

24,196

 

 

 

29,841

 

Interest income

 

(841

)

 

 

(1,935

)

Loss before income taxes

 

(41,968

)

 

 

(46,563

)

Income tax expense (benefit)

 

1,309

 

 

 

(7,212

)

Net loss

$

(43,277

)

 

$

(39,351

)

 

 

 

 

Basic loss per common share:

 

 

 

Net loss per share

$

(1.66

)

 

$

(1.52

)

Weighted average common shares outstanding

 

26,089,860

 

 

 

25,837,005

 

Diluted loss per common share:

 

 

 

Net loss per share

$

(1.66

)

 

$

(1.52

)

Weighted average common shares outstanding

 

26,089,860

 

 

 

25,837,005

 

 

 

 

 

GRAFTECH INTERNATIONAL LTD. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

 

Three Months Ended

March 31,

 

 

2026

 

 

 

2025

 

Cash flow from operating activities:

 

 

 

Net loss

$

(43,277

)

 

$

(39,351

)

Adjustments to reconcile net loss to cash provided by (used in) operations:

 

 

 

Depreciation and amortization

 

15,048

 

 

 

13,783

 

Deferred income tax expense (benefit)

 

141

 

 

 

(7,310

)

Non-cash stock-based compensation expense

 

1,839

 

 

 

580

 

Non-cash interest expense

 

1,948

 

 

 

1,948

 

Lower of cost or market inventory valuation adjustment

 

5,258

 

 

 

2,783

 

Gain on sale of assets

 

(12,279

)

 

 

 

Changes in assets and liabilities:

 

 

 

Accounts receivable, net

 

(6,761

)

 

 

5,396

 

Inventories

 

(3,244

)

 

 

(23,371

)

Prepaid and other current assets

 

4,629

 

 

 

(3,860

)

Income taxes payable

 

(254

)

 

 

(866

)

Accounts payable and other accruals

 

5,530

 

 

 

103

 

Interest payable

 

16,743

 

 

 

16,935

 

Change in Tax Receivable Agreement

 

 

 

 

(2,022

)

Other

 

(255

)

 

 

3,066

 

Net cash used in operating activities

 

(14,934

)

 

 

(32,186

)

Cash flow from investing activities:

 

 

 

Capital expenditures

 

(12,145

)

 

 

(10,281

)

Proceeds from the sale of fixed assets

 

9,315

 

 

 

29

 

Net cash used in investing activities

 

(2,830

)

 

 

(10,252

)

Cash flow from financing activities:

 

 

 

Payments for taxes related to net share settlement of equity awards

 

(339

)

 

 

(213

)

Principal payments under finance lease obligations

 

(34

)

 

 

(24

)

Net cash used in financing activities

 

(373

)

 

 

(237

)

Net change in cash and cash equivalents

 

(18,137

)

 

 

(42,675

)

Effect of exchange rate changes on cash and cash equivalents

 

(46

)

 

 

710

 

Cash and cash equivalents at beginning of period

 

138,427

 

 

 

256,248

 

Cash and cash equivalents at end of period

$

120,244

 

 

$

214,283

 

NON-GAAP RECONCILIATIONS

(Dollars in thousands, except per share and per MT data)

(Unaudited)

The following tables reconcile our non-GAAP financial measures to the most directly comparable GAAP measures:

 

Reconciliation of Net Loss to Adjusted Net Loss

 

 

 

 

 

Q1 2026

Q4 2025

Q1 2025

 

 

 

 

Net loss

$

(43,277

)

$

(65,116

)

$

(39,351

)

 

 

 

 

Diluted loss per common share:

 

 

 

Net loss per share

$

(1.66

)

$

(2.50

)

$

(1.52

)

Weighted average shares outstanding

 

26,089,860

 

 

26,043,244

 

 

25,837,005

 

 

 

 

 

Adjustments, pre-tax:

 

 

 

Pension and OPEB plan expenses(1)

 

531

 

 

(3,109

)

 

628

 

Foreign currency remeasurement(2)

 

(76

)

 

867

 

 

(17

)

Stock-based compensation expense(3)

 

1,839

 

 

1,518

 

 

580

 

Gain on sale of assets(4)

 

(12,279

)

 

 

 

 

Tax Receivable Agreement adjustment(5)

 

 

 

 

 

11

 

Debt modification costs(6)

 

 

 

 

 

5,361

 

Total non-GAAP adjustments pre-tax

 

(9,985

)

 

(724

)

 

6,563

 

Income tax impact on non-GAAP adjustments(7)

 

265

 

 

(1,954

)

 

1,367

 

Adjusted net loss

$

(53,527

)

$

(63,886

)

$

(34,155

)

Reconciliation of Loss Per Share to Adjusted Loss Per Share

 

 

 

 

 

Q1 2026

Q4 2025

Q1 2025

 

 

 

 

Loss per share

$

(1.66

)

$

(2.50

)

$

(1.52

)

Adjustments per share:

 

 

 

Pension and OPEB plan expenses(1)

 

0.02

 

 

(0.12

)

 

0.02

 

Foreign currency remeasurement(2)

 

 

 

0.03

 

 

 

Stock-based compensation expense(3)

 

0.07

 

 

0.06

 

 

0.02

 

Gain on sale of assets(4)

 

(0.47

)

 

 

 

 

Tax Receivable Agreement adjustment(5)

 

 

 

 

 

 

Debt modification costs(6)

 

 

 

 

 

0.21

 

Total non-GAAP adjustments pre-tax per share

 

(0.38

)

 

(0.03

)

 

0.25

 

Income tax impact on non-GAAP adjustments per share(7)

 

0.01

 

 

(0.08

)

 

0.05

 

Adjusted loss per share

$

(2.05

)

$

(2.45

)

$

(1.32

)

Reconciliation of Net Loss to Adjusted EBITDA

 

 

 

 

 

Q1 2026

Q4 2025

Q1 2025

 

 

 

 

Net loss

$

(43,277

)

$

(65,116

)

$

(39,351

)

Add:

 

 

 

Depreciation and amortization

 

15,048

 

 

15,799

 

 

13,783

 

Interest expense

 

24,196

 

 

24,281

 

 

29,841

 

Interest income

 

(841

)

 

(1,448

)

 

(1,935

)

Income taxes

 

1,309

 

 

5,308

 

 

(7,212

)

EBITDA

 

(3,565

)

 

(21,176

)

 

(4,874

)

Adjustments:

 

 

 

Pension and OPEB plan expenses(1)

 

531

 

 

(3,109

)

 

628

 

Foreign currency remeasurement(2)

 

(76

)

 

867

 

 

(17

)

Stock-based compensation expense(3)

 

1,839

 

 

1,518

 

 

580

 

Gain on sale of assets(4)

 

(12,279

)

 

 

 

 

Tax Receivable Agreement adjustment(5)

 

 

 

 

 

11

 

Adjusted EBITDA

$

(13,550

)

$

(21,900

)

$

(3,672

)

Reconciliation of Net Cash Used in Operating Activities to Free Cash Flow and Adjusted Free Cash Flow

 

 

 

 

 

Q1 2026

Q4 2025

Q1 2025

 

 

 

 

Net cash used in operating activities

$

(14,934

)

$

(20,894

)

$

(32,186

)

Capital expenditures

 

(12,145

)

 

(18,371

)

 

(10,281

)

Free cash flow

 

(27,079

)

 

(39,265

)

 

(42,467

)

 

 

 

 

Debt modification costs(8)

 

 

 

 

 

2,193

 

Adjusted free cash flow

$

(27,079

)

$

(39,265

)

$

(40,274

)

Reconciliation of Cost of Goods Sold to Cash Cost of Goods Sold per MT

 

 

 

Q1 2026

Q4 2025

Q1 2025

 

 

 

 

Cost of goods sold

$

134,833

$

128,805

$

110,765

Less:

 

 

 

Depreciation and amortization(9)

 

13,477

 

14,229

 

12,144

Cost of goods sold – by-products and other(10)

 

13,238

 

5,672

 

8,415

Cash cost of goods sold

 

108,118

 

108,904

 

90,206

Sales volume (in thousands of MT)

 

28.1

 

27.1

 

24.7

Cash cost of goods sold per MT

$

3,848

$

4,019

$

3,652

(1)

Net periodic benefit cost for our pension and OPEB plans, including a mark-to-market adjustment, representing actuarial gains and losses that result from the remeasurement of plan assets and obligations due to changes in assumptions or experience. We recognize the actuarial gains and losses in connection with the annual remeasurement in earnings in the fourth quarter of each year.

(2)

Non-cash (gains) losses from foreign currency remeasurement of non-operating assets and liabilities of our non-U.S. subsidiaries where the functional currency is the U.S. dollar.

(3)

Non-cash expense for stock-based compensation awards.

(4)

Gain recognized related to the sale of assets associated with previously divested operations.

(5)

Prior to the second quarter of 2025, when the Company established a full valuation allowance, represents expense adjustment for future payment to our sole pre-Initial Public Offering stockholder for tax assets that have been utilized.

(6)

Debt modification costs related to the December 2024 debt transactions, which are recognized in interest expense on the Condensed Consolidated Statements of Operations.

(7)

Represents the tax impact on the non-GAAP adjustments.

(8)

Cash payments of debt modification costs related to the December 2024 debt transactions, which are recognized in interest expense on the Condensed Consolidated Statements of Operations and recognized in net cash used in operating activities on the Condensed Consolidated Statements of Cash Flows.

(9)

Reflects the portion of depreciation and amortization that is recognized in cost of goods sold.

(10)

Primarily reflects cost of goods sold associated with the portion of our sales that consists of deliveries of by-products of the manufacturing processes.

 

Michael Dillon

216-676-2000

[email protected]

KEYWORDS: Ohio Indiana Kentucky United States North America

INDUSTRY KEYWORDS: Consumer Electronics Technology Manufacturing Mining/Minerals Natural Resources Other Manufacturing Steel Alternative Energy Energy Hardware Chemicals/Plastics

MEDIA:

Logo
Logo

Investor Notice: The Mister Car Wash (NASDAQ:MCW) Board may have Breached their Duties to Investors – Contact BFA Law about the Pending Investigation

Mister Car Wash, Inc. Shareholders are notified that the company has revealed new details about the pending transaction which are relevant to BFA Law’s ongoing investigation into LGP’s $7.00 per share Take Private Transaction

NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP notifies stockholders of Mister Car Wash, Inc. (NASDAQ: MCW) that new details have emerged related to BFA Law’s ongoing investigation into the company’s board of directors and its controlling stockholder, LGP, for potential breaches of their fiduciary duties to shareholders in connection with the pending take-private sale of Mister Car Wash that is slated to cash out every public stockholder for $7 per share.

If you are a current shareholder of Mister Car Wash, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/mister-car-wash-investigation.

Why is Mister Car Wash being Investigated?

On February 18, 2026, Mister Car Wash announced that it had agreed to be acquired by Leonard Green & Partners, L.P. (“LGP”) for $7.00 per share. This price may represent an unfairly low price being paid to Mister Car Wash’s stockholders and may be the result of conflicts of interest between Mister Car Wash’s board of directors and LGP.

LGP is the largest owner of Mister Car Wash stock, owning over 66% of the company’s common stock. As Mister Car Wash noted in its most recent annual report (SEC form 10-k) “[f]or as long as LGP owns more than 50% of [Mister Car Wash’s] common stock it will be able to exert a controlling influence over all matters requiring stockholder approval, including the nomination and election of directors and approval of significant corporate transactions, such as a merger or other sale of our Company or its assets.” As the controlling stockholder of Mister Car Wash, LGP owes fiduciary duties to the public stockholders of Mister Car Wash.

LGP has already used its shares to give stockholder approval to the take-private sale, and the company does not plan to solicit any further votes from public stockholders. With the ability to approve the sale of Mister Car Wash to itself, needing only its own votes, LGP is incentivized to execute the deal as cheaply as possible.

BFA Law is conducting an ongoing investigation into Mister Car Wash’s board of directors and LGP to ascertain whether they have breached fiduciary duties to Mister Car Wash’s stockholders in connection with the contemplated transaction.

On April 3, 2026, Mister Car Wash filed new disclosures with the SEC on Schedule 13E-3. In that form, the company revealed the members of the special committee that negotiated the terms of the transaction on behalf of the company. BFA Law’s investigation has identified potential deficiencies in the independence of those special committee members. Mister Car Wash also revealed new details about the background of how the transaction was negotiated. BFA Law is continuing to investigate whether Mister Car Wash’s management conducted a sufficient sales process in light of this new information—including into whether the company ever genuinely considered alternative purchasers aside from LGP.

Click here for more information:

https://www.bfalaw.com/cases/mister-car-wash-investigation

What Can You Do?

If you are a current holder of Mister Car Wash stock you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/mister-car-wash-investigation

Or contact:
Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/mister-car-wash-investigation

Attorney advertising. Past results do not guarantee future outcomes.



nVent Electric plc First Quarter 2026 Financial Results Available on Company’s Website

LONDON, May 01, 2026 (GLOBE NEWSWIRE) — nVent Electric plc (NYSE:NVT) (“nVent”), a global leader in electrical connection and protection solutions, reported first quarter 2026 financial results today through an earnings release posted on the company’s Investor Relations website at http://investors.nvent.com. The earnings release will be furnished with the Securities and Exchange Commission on a Form 8-K and is available here. The company will also hold a conference call with analysts and investors at 9:00 a.m. ET.

Conference Call and Webcast Details

The call can be accessed via webcast at http://investors.nvent.com or by dialing 1-833-630-1071 or 1-412-317-1832. Once available, a replay of the conference call will be accessible through May 15, 2026, by dialing 1-855-669-9658 or 1-412-317-0088, along with the access code 3392967.

About nVent

nVent is a leading global provider of electrical connection and protection solutions. We believe our inventive electrical solutions enable safer systems and ensure a more secure world. We design, manufacture, market, install and service high performance products and solutions that connect and protect some of the world’s most sensitive equipment, buildings and critical processes. We offer a comprehensive range of systems protection and electrical connections solutions across industry-leading brands that are recognized globally for quality, reliability and innovation. Our principal office is in London and our management office in the United States is in Minneapolis. Our robust portfolio of leading electrical product brands dates back more than 100 years and includes nVent CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF and TRACHTE. Learn more at www.nvent.com.

nVent, CADDY, ERICO, HOFFMAN, ILSCO, SCHROFF and TRACHTE are trademarks owned or licensed by nVent Services GmbH or its affiliates.

Investor Contact

Tony Riter
Vice President, Investor Relations
nVent
763.204.7750
[email protected]

Media Contact

Kevin H. King
Vice President, Global Communications
nVent
763.291.0526
[email protected]



TC Energy reports strong first quarter 2026 operating and financial results

Safety and operational excellence drive seven delivery records across North America

Approves US$1.5 billion Columbia Gas expansion project, extending reach into high-demand market

CALGARY, Alberta, May 01, 2026 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) released its first quarter results today. François Poirier, TC Energy’s President and Chief Executive Officer commented, “We entered 2026 with strong momentum. Our best safety performance in six years drove seven delivery records across North America, while consistent execution delivered strong financial results, with comparable EBITDA1 up 14 per cent and segmented earnings up 10 per cent compared to first quarter 2025.” Poirier continued, “Constructive market conditions continue to translate into attractive, disciplined growth opportunities. Today, I’m pleased to announce the Appalachia Supply Project, a US$1.5 billion, low‑risk, strategic expansion on our Columbia Gas system that is expected to strengthen our position and create a new platform for capital-efficient opportunities in a high‑growth power and industrial corridor. Customer demand continues to validate our strategy; our recent 2.5x oversubscribed open season on Crossroads reinforces the strength of our project origination backlog and provides clear visibility to long-term, high-quality growth.”

Financial Highlights

(All financial figures are unaudited and in Canadian dollars unless otherwise noted)

  • First quarter 2026 financial results:
    • Comparable earnings1 of $1.0 billion or $0.99 per common share1 compared to $1.0 billion or $0.95 per common share in first quarter 2025
    • Net income attributable to common shares of $0.9 billion or $0.86 per common share compared to $1.0 billion or $0.94 per common share in first quarter 2025
    • Comparable EBITDA of $3.1 billion compared to $2.7 billion in first quarter 2025
    • Segmented earnings of $2.2 billion compared to $2.0 billion in first quarter 2025
  • TC Energy’s Board of Directors declared a quarterly dividend of $0.8775 per common share for the quarter ending June 30, 2026
  • Reaffirming 2026 outlook:
    • We expect our 2026 comparable EBITDA and comparable earnings per common share (EPS) outlooks to be higher than 2025, consistent with our 2025 Annual Report
    • Comparable EBITDA is expected to be $11.6 to $11.8 billion
    • Capital expenditures are anticipated to be $6.0 to $6.5 billion prior to adjustments for non-controlling interests, or $5.5 to $6.0 billion of net capital expenditures.2

_____________________________________

1 Comparable EBITDA, comparable earnings and comparable earnings per common share are non-GAAP measures used throughout this news release. These measures do not have any standardized meaning under GAAP and therefore are unlikely to be comparable to similar measures presented by other companies. The most directly comparable GAAP measures are Segmented earnings, Net income attributable to common shares and Net income per common share, respectively. We do not forecast Segmented earnings. For more information on non-GAAP measures, refer to the Non-GAAP and Supplementary financial measure section of this news release.
2 Net capital expenditures are adjusted for the portion attributed to non-controlling interests and is a supplementary financial measure used throughout this news release. For more information on non-GAAP measures and the supplementary financial measure, refer to the Non-GAAP and Supplementary financial measure section of this news release.

Operational Highlights

  • Canadian Natural Gas Pipelines deliveries averaged 29.7 Bcf/d, up three per cent compared to first quarter 2025 and set a new all-time delivery record of 33.2 Bcf on Jan. 22, 2026
    • Total NGTL system receipts averaged 14.6 Bcf/d, comparable to first quarter 2025
    • NGTL System deliveries set a new all-time delivery record of 18.3 Bcf on Jan. 22, 2026
    • Canadian Mainline Western receipts averaged 5.0 Bcf/d, in line with first quarter 2025
  • U.S. Natural Gas Pipelines daily average flows were 32.6 Bcf/d, up five per cent compared to first quarter 2025
    • U.S. Natural Gas Pipelines achieved an all-time delivery record of 39.9 Bcf on Jan. 29, 2026
    • ANR System deliveries set a new all-time delivery record of 10.6 Bcf on Jan. 29, 2026
    • Six individual pipelines set new all-time delivery records in first quarter 2026
    • Deliveries to LNG facilities averaged 3.9 Bcf/d, up 12 per cent compared to first quarter 2025
  • Mexico Natural Gas Pipelines flows averaged 2.8 Bcf/d, lower than first quarter 2025 primarily attributed to adjustments to pipeline flows
    • Deliveries to power generation facilities averaged 1.2 Bcf/d in first quarter 2026, in line with first quarter 2025
  • Bruce Power achieved 88.2 per cent availability in first quarter 2026, primarily reflecting a planned outage on Unit 8
  • Cogeneration power plant fleet achieved 99.5 per cent availability in first quarter 2026.

 Project Highlights

  • Approved the Ap
    palachia Supply Project with an expected build multiple1 of 7.3x: an expansion project of our Columbia Gas system designed to provide up to 0.8 Bcf/d of capacity to facilitate expanded new natural gas-fired power generation. The project has an anticipated in-service date of 2030 and an estimated project cost of approximately US$1.5 billion.
  • Coastal GasLink Limited Partnership (Coastal GasLink LP) entered into commercial agreements with LNG Canada, establishing a framework for advancing a proposed CGL Phase 2 Expansion. The commercial structure of the agreements includes limits on CGL’s capital commitments and overall liability for construction cost and schedule risks.
  • Reached settlement agreements with customers on Canadian Mainline, ANR and Great Lakes:

    • Canadian Mainline: filed an application with the Canada Energy Regulator seeking approval of a four‑year negotiated settlement for the period from January 2027 through December 2030. The proposed settlement maintains a return on equity of 10.1 per cent on 40 per cent deemed common equity and includes an incentive mechanism which provides the ability to outperform the approved rate of return. In addition, TC Energy has committed up to $200 million of capital to support incremental capacity, with targeted returns that exceed the approved return on equity.
    • ANR: on Mar. 18, 2026, ANR notified FERC that it has reached a settlement-in-principle with its customers on the ANR Section 4 Rate Case. The final settlement is expected to include an increase relative to pre-filed rates, subject to revision following completion and approval of settlement terms, which is anticipated in third quarter 2026.
    • Great Lakes: on April 28, 2026, Great Lakes notified FERC that it has reached a settlement-in-principle with its customers, subject to revision following completion and approval of settlement terms, which we anticipate in fourth quarter 2026.
  • Advanced key projects and placed projects into service:

    • Placed $0.4 billion of capacity projects in service on the NGTL System, including $0.1 billion of Multi-Year Growth (MYGP) projects
      • Completed construction of the Berland River non‑emitting electric compressor unit on the Valhalla North and Berland River project with a capital cost of approximately $0.3 billion. The unit is expected to be operational in the second half of 2026.

_____________________________________

1 Build multiple is a non-GAAP ratio calculated by dividing capital expenditures by comparable EBITDA. Please note our method for calculating build multiple may differ from methods used by other entities. Therefore, it may not be comparable to similar measures presented by other entities. For more information on non-GAAP measures and the supplementary financial measure, refer to the Non-GAAP and Supplementary financial measure section of this news release.

    three months ended

March 31
(millions of $, except per share amounts)   2026
    2025
 
         
Income        
Net income (loss) attributable to common shares     899       978  
per common share – basic   $
0.86
    $0.94  
         
Segmented earnings (losses)        
Canadian Natural Gas Pipelines     509       516  
U.S. Natural Gas Pipelines     1,075       1,109  
Mexico Natural Gas Pipelines     389       211  
Power and Energy Solutions     201       135  
Corporate     (3 )     (5 )
Total segmented earnings (losses)     2,171       1,966  
         
Comparable EBITDA        
Canadian Natural Gas Pipelines     919       890  
U.S. Natural Gas Pipelines     1,497       1,367  
Mexico Natural Gas Pipelines     432       233  
Power and Energy Solutions     243       224  
Corporate     (3 )     (5 )
Comparable EBITDA     3,088       2,709  
Depreciation and amortization     (723 )     (678 )
Interest expense     (838 )     (840 )
Allowance for funds used during construction     39       248  
Foreign exchange gains (losses), net included in comparable earnings     1       (10 )
Interest income and other     33       51  
Income tax (expense) recovery included in comparable earnings     (316 )     (292 )
Net (income) loss attributable to non-controlling interests included in comparable earnings     (225 )     (177 )
Preferred share dividends     (28 )     (28 )
Comparable earnings     1,031       983  
Comparable earnings per common share   $
0.99
    $0.95  
                 

    three months ended

March 31
(millions of $, except per share amounts)     2026     2025
         
Cash flows        
Net cash provided by operations     2,603     1,359
Comparable funds generated from operations1     2,336     1,949
Capital spending2     1,307     1,809
Dividends declared        
per common share   $
0.8775
  $0.85
Basic common shares outstanding (millions)        
– weighted average for the period     1,041     1,039
– issued and outstanding at end of period     1,042     1,040
             
  1. Comparable funds generated from operations is a non-GAAP measure used throughout this news release. This measure does not have any standardized meaning under GAAP and therefore is unlikely to be comparable to similar measures presented by other companies. The most directly comparable GAAP measure is net cash provided by operations. For more information on non-GAAP measures, refer to the Non-GAAP and Supplementary financial measure section of this news release.
  2. Capital spending reflects cash flows associated with our Capital expenditures, Capital projects in development and Contributions to equity investments. Refer to Note 4, Segmented information of our Condensed consolidated financial statements for additional information.

CEO Message

Throughout the first quarter of 2026, TC Energy continued to build on momentum and demonstrate strong execution against a clear set of strategic priorities. Our unwavering focus on safety and operational excellence continues to support the availability and reliability of our assets that continue to drive strong operational and financial results. For the three months ended Mar. 31, 2026, comparable EBITDA increased 14 per cent and segmented earnings increased 10 per cent compared to first quarter 2025. Our consistent results reinforce the strength and resilience of our low-risk business model and our ability to deliver solid growth and repeatable performance despite ongoing macroeconomic volatility. Additionally, during Winter Storm Fern, our team continued to deliver exceptional reliability that contributed in part to the seven delivery records we achieved on our system during the quarter. We remain focused on maximizing the value of our assets through safety and operational excellence, executing our selective portfolio of growth projects, and ensuring financial strength and agility.

Sustained growth in natural gas and power demand in the U.S. continues to translate into attractive investment opportunities across our diversified portfolio. Consistent with our capital allocation priorities, we have announced a strategic expansion project on our Columbia Gas system that reinforces visibility to incremental growth into the next decade. The US$1.5 billion Appalachia Supply Project on our Columbia Gas system extends our reach into a corridor that serves multiple high‑growth power and industrial markets. The expansion project is supported by a 20‑year take‑or‑pay contract backed by an investment‑grade utility and is expected to deliver a 7.3x build multiple. The project is designed to provide up to 0.8 Bcf/d of capacity to facilitate expanded new natural gas-fired power generation and has an anticipated in-service date in 2030. The project is capable of up to 2.0 Bcf/d through future expansions, creating additional opportunities to pursue capital‑efficient, high‑value growth projects as diversified demand from electrification, economic development, and data centres is anticipated to accelerate long‑duration load growth in the U.S. Heartland market. The project represents a deliberate investment in a strategic, high‑growth corridor that further strengthens the long‑term competitive positioning of the Columbia Gas Transmission system and establishes a durable platform for repeatable value creation into the next decade.

Supported by strong customer demand, on Feb. 9, 2026, we launched a non-binding expansion project open season on our Crossroads Pipeline system for up to 1.5 Bcf/d of capacity to serve growing markets in Northern Indiana, Illinois, Iowa, and South Dakota. The open season was 2.5 times oversubscribed, reflecting the asset’s unique connectivity and bi-directional flexibility. By linking multiple major pipeline systems, the Crossroads pipeline is well positioned to support the anticipated substantial growth in Midwest power demand, and our established footprint enables capital‑efficient expansion and reduced execution risk. The Crossroads open season builds off the momentum of the non-binding expansion project open season on our Columbia Gas Transmission system that closed on Jan. 9 , 2026 and received bids at three times the proposed project capacity. These developments illustrate how connectivity between our systems enables highly competitive pathways from premium supply to high‑quality demand markets and reinforces the value and scalability of our integrated footprint.

Broader market dynamics, including volatility and structural change in the global LNG market, continue to underscore our role as a critical conduit for North American supply to global markets. As the only company serving every major LNG export shoreline in North America, transporting approximately 30 per cent of feedgas bound for export, we continue to see strong demand across our system. Deliveries to U.S. LNG facilities increased 12 per cent year‑over‑year, averaging 3.9 Bcf/d in the first quarter 2026. Against this backdrop, we reached an important milestone as Coastal GasLink LP entered into commercial agreements with LNG Canada, establishing a framework to advance a proposedCGL Phase 2 Expansion. The commercial structure of the agreements includes limits on CGL’s capital commitments and overall liability for construction cost and schedule risks, reflecting our disciplined approach to risk allocation as we advance critical infrastructure projects across North America.

In both Canada and the U.S., we made meaningful progress reaching settlement agreements with customers on the Canadian Mainline, ANR and Great Lakes. On the Canadian Mainline, we filed an application with the CER seeking approval of a four‑year negotiated settlement covering the period from January 2027 through December 2030, maintaining a return on equity of 10.1 per cent on 40 per cent deemed common equity, with an incentive mechanism designed to encourage cost management and revenue optimization and provides the opportunity to outperform the approved rate of return. In addition, TC Energy has committed up to $200 million of capital to support incremental capacity, with targeted returns that exceed the approved return on equity. On ANR, we reached a settlement‑in‑principle with customers in the Section 4 rate case, which is expected to include an increase relative to pre-filed rates, subject to revision following completion and approval of settlement terms, which we anticipate in third quarter of 2026. On Great Lakes, we reached a settlement-in-principle with customers, subject to revision following completion and approval of settlement terms, which we anticipate in fourth quarter 2026. Together, these developments reinforce the stability and long‑term strength of our regulated earnings profile.

Execution remained strong across the portfolio. During the quarter, we placed approximately $0.4 billion of capacity projects into service on the NGTL System, including $0.1 billion of MYGP projects, on time and on budget. We completed construction of the approximately $0.3 billion Berland River unit, a non‑emitting electric compressor on the Valhalla North and Berland River project which is expected to be operational in the second half of 2026. At Bruce Power, we continue to track to cost and schedule on the Major Component Replacement (MCR) Unit 3 and 4.

Disciplined execution and prudent capital spending continue to strengthen the balance sheet and advance our strategic priorities, while keeping us on track to achieve our long‑term target of 4.75x debt-to-EBITDA.1 Together, these milestones reflect the strength and resilience of our asset base, our ability to execute reliably at scale, and our focused, capital‑efficient approach to growth that enhances long‑term value for TC Energy shareholders.

_____________________________________

1 Debt-to-EBITDA is a non-GAAP ratio. Adjusted debt and adjusted comparable EBITDA are non-GAAP measures used to calculate debt-to-EBITDA. For more information on non-GAAP measures, refer to the non-GAAP measures of this news release. These measures do not have any standardized meaning under GAAP and therefore are unlikely to be comparable to similar measures presented by other companies.

Dividends

TC Energy’s Board of Directors declared a quarterly dividend of $0.8775 per common share for the quarter ending June 30, 2026, equivalent to $3.51 on an annualized basis. The common share dividend is payable on July 31, 2026, to shareholders of record at the close of business on June 30, 2026.

The Board of Directors also declared dividends on the outstanding Cumulative First Preferred Shares (preferred shares). Information related to the preferred shares dividends are available on our website under TC Energy – Shareholder Information.

Teleconference and Webcast

We will hold a teleconference and webcast on Friday, May 1 at 6:30 a.m. (MT) / 8:30 a.m. (ET) to discuss our first quarter 2026 financial results. Presenters will include François Poirier, President and Chief Executive Officer; Sean O’Donnell, Executive Vice-President and Chief Financial Officer; and other members of the executive leadership team.

Members of the investment community and other interested parties are invited to participate by calling 1-833-752-3826 (Canada/U.S. toll free) or 1-647-846-8864 (International toll). No passcode is required. Please dial in 15 minutes prior to the start of the call. Alternatively, participants may pre-register for the call here. Upon registering, you will receive a calendar booking by email with dial in details and a unique PIN. This process will bypass the operator and avoid the queue. Registration will remain open until the end of the conference call.

A live webcast of the teleconference will be available on TC Energy’s website at TC Energy — Events and presentations or via the following URL: https://www.gowebcasting.com/14393. The webcast will be available for replay following the meeting.

A replay of the teleconference will be available two hours after the conclusion of the call until midnight ET on Friday, May 8, 2026. Please call 1-855-669-9658 (Canada/U.S. toll free) or 1-412-317-0088 (International toll) and enter passcode 4884355.

The unaudited interim Condensed consolidated financial statements and Management’s Discussion and Analysis (MD&A) are available on our website at www.TCEnergy.com and will be filed today under TC Energy’s profile on SEDAR+ at


www.sedarplus.ca


and with the U.S. Securities and Exchange Commission on EDGAR at


www.sec.gov

.

About TC Energy

We are a leader in North American energy infrastructure, spanning Canada, the U.S. and Mexico. Every day, our dedicated team proudly connects the world to the energy it needs, moving over 30 per cent of the cleaner-burning natural gas used across the continent. Complemented by strategic ownership and low-risk investments in power generation, our infrastructure fuels industries and generates affordable, reliable and sustainable power across North America, while enabling LNG exports to global markets.

Our business is based on the connections we make. By partnering with communities, businesses and leaders across our extensive energy network, we unlock opportunity today and for generations to come.

TC Energy’s common shares trade on the Toronto (TSX) and New York (NYSE) stock exchanges under the symbol TRP. To learn more, visit us at TCEnergy.com.

Forward-Looking Information

This release contains certain information that is forward-looking and is subject to important risks and uncertainties and is based on certain key assumptions. Forward-looking statements are usually accompanied by words such as “anticipate”, “expect”, “believe”, “may”, “will”, “should”, “estimate” or other similar words. Forward-looking statements in this document may include, but are not limited to, statements related to expectations with respect to expected comparable EBITDA, comparable earnings in total and per common share and the sources and drivers thereof, expectations with respect to anticipated capital expenditures and net capital expenditures and the timing thereof, expectations with respect to identified approved and future projects, including associated capital expenditures, timelines, in-service dates, and outcomes, expectations with respect to completed projects and expected impacts thereof, expectations on rate case settlements and timing of approved settlement terms, expectations with respect to our ability to deploy capital at targeted build multiples and achieve expected returns on invested capital, expectations with respect to the approximate value of projects to be placed in-service in subsequent years, expectations with respect to our strategic priorities, and the execution thereof, expectation on the value of and risk profile of our incremental growth projects, expectations with respect to our ability to maximize the value of our assets through safety and operational excellence, expectations regarding financial ratio targets such as debt-to-EBITDA, expectations on repeatable value creation through the next decade, expected cost and schedules for planned projects, including projects under construction and in development, expectations about energy demand levels and drivers thereof, expectations regarding the competitive positioning and long-term value contribution of specific assets and our ability to capture growth opportunities, expectations about our ability to execute our identified portfolio of growth projects and ensure financial strength and agility, our ability to deliver low-risk, solid growth and repeatable performance, expected industry, market and economic conditions, and ongoing trade negotiations, including their expected impact on our business, customers and suppliers. Our forward-looking information is subject to important risks and uncertainties and is based on certain key assumptions. Forward-looking statements and future-oriented financial information in this document are intended to provide TC Energy security holders and potential investors with information regarding TC Energy and its subsidiaries, including management’s assessment of TC Energy’s and its subsidiaries’ future plans and financial outlook. All forward-looking statements reflect TC Energy’s beliefs and assumptions based on information available at the time the statements were made and as such are not guarantees of future performance. As actual results could vary significantly from the forward-looking information, you should not put undue reliance on forward-looking information and should not use future-oriented information or financial outlooks for anything other than their intended purpose. We do not update our forward-looking information due to new information or future events, unless we are required to by law. For additional information on the assumptions made, and the risks and uncertainties which could cause actual results to differ from the anticipated results, refer to the most recent Quarterly Report to Shareholders and the 2025 Annual Report filed under TC Energy’s profile on SEDAR+ at www.sedarplus.ca and with the U.S. Securities and Exchange Commission at www.sec.gov and the “Forward-looking information” section of our Report on Sustainability which is available on our website at www.TCEnergy.com.

Non-GAAP and Supplementary Financial Measure

This release contains references to the following non-GAAP measures: comparable EBITDA, comparable earnings, comparable earnings per common share and comparable funds generated from operations. It also contains references to debt-to-EBITDA, a non-GAAP ratio, which is calculated using adjusted debt and adjusted comparable EBITDA, each of which are non-GAAP measures. These non-GAAP measures do not have any standardized meaning as prescribed by GAAP and therefore may not be comparable to similar measures presented by other entities. These non-GAAP measures are calculated by adjusting certain GAAP measures for specific items we believe are significant but not reflective of our underlying operations in the period. These comparable measures are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable except as otherwise described in the Condensed consolidated financial statements and MD&A. Refer to: (i) each business segment for a reconciliation of comparable EBITDA to segmented earnings (losses); (ii) Consolidated results section for reconciliations of comparable earnings and comparable earnings per common share to Net income attributable to common shares and Net income per common share, respectively; and (iii) Financial condition section for a reconciliation of comparable funds generated from operations to Net cash provided by operations. Refer to the Non-GAAP Measures section of the MD&A in our most recent quarterly report for more information about the non-GAAP measures we use. The MD&A is included with, and forms part of, this release. The MD&A can be found on SEDAR+ at www.sedarplus.ca under TC Energy’s profile.

With respect to non-GAAP measures used in the calculation of debt-to-EBITDA, adjusted debt is defined as the sum of Reported total debt, including Notes payable, Long-term debt, Current portion of long-term debt and Junior subordinated notes, as reported on our Consolidated balance sheet as well as Operating lease liabilities recognized on our Consolidated balance sheet and 50 per cent of Preferred shares as reported on our Consolidated balance sheet due to the debt-like nature of their contractual and financial obligations, less Cash and cash equivalents as reported on our Consolidated balance sheet and 50 per cent of Junior subordinated notes as reported on our Consolidated balance sheet due to the equity-like nature of their contractual and financial obligations. Adjusted comparable EBITDA is calculated as the sum of comparable EBITDA from continuing operations and comparable EBITDA from discontinued operations excluding Operating lease costs recorded in Plant operating costs and other in our Consolidated statement of income and adjusted for Distributions received in excess of (income) loss from equity investments and a Loan from affiliate as reported in our Consolidated statement of cash flows which we believe is more reflective of the cash flows available to TC Energy to service our debt and other long-term commitments. Beginning in 2025, we entered into a subordinated demand revolving credit facility to borrow funds from the Sur de Texas joint venture and received proceeds totaling $111 million during the year. We believe that debt-to-EBITDA provides investors with useful information as it reflects our ability to service our debt and other long-term commitments. See the Reconciliation section for reconciliations of adjusted debt and adjusted comparable EBITDA for the years ended Dec. 31, 2023, 2024 and 2025.

This release contains references to build multiple, which is non-GAAP ratio which is calculated using capital expenditures and comparable EBITDA, of which comparable EBITDA is a non-GAAP measure. We believe build multiple provides investors with a useful measure to evaluate capital projects.

This release also contains references to net capital expenditures, which is a supplementary financial measure. Net capital expenditures represent capital costs incurred for growth projects, maintenance capital expenditures, contributions to equity investments and projects under development, adjusted for the portion attributed to non-controlling interests in the entities we control. Net capital expenditures reflect capital costs incurred during the period, excluding the impact of timing of cash payments. We use net capital expenditures as a key measure in evaluating our performance in managing our capital spending activities in comparison to our capital plan.

Reconciliation

The following is a reconciliation of adjusted debt and adjusted comparable EBITDA1.

    year ended December 31
(millions of Canadian $)   2025     2024     2023  
             
Reported total debt   60,086     59,366     63,201  
Management adjustments:            
Debt treatment of preferred shares2   1,128     1,250     1,250  
Equity treatment of junior subordinated notes3   (6,047 )   (5,524 )   (5,144 )
Cash and cash equivalents   (168 )   (801 )   (3,678 )
Operating lease liabilities   431     511     457  
Adjusted debt   55,430     54,802     56,086  
             
Comparable EBITDA from continuing operations4   10,952     10,049     9,472  
Comparable EBITDA from discontinued operations4       1,145     1,516  
Operating lease cost   112     117     105  
Distributions received in excess of (income) loss from equity investments   342     67     (123 )
Loan from affiliate   111          
Adjusted Comparable EBITDA   11,517     11,378     10,970  
             
Adjusted Debt/Adjusted Comparable EBITDA
1
  4.8     4.8     5.1  
                   
  1. Adjusted debt and adjusted comparable EBITDA are non-GAAP measures. The calculations are based on management methodology. Individual rating agency calculations will differ.
  2. 50 per cent debt treatment on $2.3 billion of preferred shares as of Dec. 31, 2025.
  3. 50 per cent equity treatment on $12.1 billion of junior subordinated notes as of Dec. 31, 2025. U.S. dollar-denominated notes translated at Dec. 31, 2025, USD/CAD foreign exchange rate of 1.37.
  4. Comparable EBITDA from continuing operations and Comparable EBITDA from discontinued operations are non-GAAP financial measures. See the Forward-looking information and Non-GAAP measures sections in our 2025 Annual Report for more information. Comparable EBITDA from discontinued operations represents nine months of Liquids Pipelines earnings in 2024 compared to a full year of earnings in 2023. Refer to the Discontinued operations section in our 2024 Annual Report for additional information.

Download full report here: tcenergy.com/siteassets/pdfs/investors/reports-and-filings/annual-and-quarterly-reports/2026/tce-2026-q1-quarterly-report.pdf

Media Inquiries:

Media Relations
[email protected]
403.920.7859 or 800.608.7859

Investor & Analyst Inquiries:
        

Investor Relations
[email protected]
403.920.7911 or 800.361.6522



Bimergen Energy to Present its $2B Growth Strategy at the Market Movers Investor Summit

Newport Beach, CA, May 01, 2026 (GLOBE NEWSWIRE) —
Bimergen Energy Corporation (NYSE American: BESS, BESS.WS), a developer, owner, and operator of utility-scale and distributed battery energy storage systems (BESS) across the United States, announced today that it will be participating in the Market Movers Investor Summit on Tuesday May 5, 2026. Bimergen’s Co-CEO & CFO Bob Brilon will deliver a corporate presentation and subsequently open the floor to questions. The presentation will take place at 2:40 P.M. ET at the historic Bank of New York.

The Market Movers Investor Summit is a premier, high-access event on Wall Street. The Inaugural program features fireside chats with Alex Rodriguez, Chairman and CEO of A-Rod Corp, and Grant Cardone, CEO of Cardone Capital, in addition to company presentations and one-on-one meetings throughout the day.

Event Details:

  • Summit Date: May 5, 2026
  • Company Presentation: Tuesday, May 5, 2026
  • Time: 2:40 P.M. ET
  • Location: 48 Wall Street, New York, NY (The original Bank of New York)

Request an invitation to attend at www.marketmoverssummit.com.

Bimergen plans to discuss its $2 billion growth strategy from its development pipeline of battery energy storage projects totaling approximately 2.0 GW of estimated capacity across key U.S. power markets, including ERCOT, PJM, WECC, CAISO and MISO. Bimergen will also discuss the project specific entity financial structure avoiding public company dilution and debt recourse. Bimergen management will discuss the simple energy arbitrage revenue model that capitalizes on the increasing demand and increasing prices for electricity while making more power available to the grid when it is needed. Bimergen’s strategy is technology agnostic, which makes them unique, and focused on owning and operating these revenue-producing battery storage farms. Bimergen’s strategy includes the use of long-term offtake agreements that support stable, contract-backed revenue streams, de-risking operating cashflows. Mr. Brilon will also discuss the status of the projects moving towards being operational in Texas in the near term.

About Bimergen Energy Corporation

Bimergen Energy Corporation (NYSE American: BESS, BESSWS) is a U.S.-based independent power producer specializing in the development, ownership, and operation of standalone battery energy storage systems (BESS). Bimergen develops utility-scale and distributed storage projects designed to provide grid reliability, renewable integration, and flexible energy solutions. Bimergen manages the full project lifecycle, including site selection, permitting, engineering, procurement, construction, and operations. Its portfolio spans multiple power markets across the United States. For more information about Bimergen Energy, please visit www.bimergen.com.

About Market Movers

Market Movers is a next-generation investor conference designed for people responsible for capital, growth, and strategic outcomes. Hosted on Wall Street inside the original Bank of New York, the event brings together public & company leaders, investors, real estate principals, founders, and operators for a focused, high-access experience. The emphasis is on meaningful conversations, real connections, and perspectives that extend beyond a single market or asset class.

To learn more about the Market Movers Investor Summit, visit: https://www.marketmoverssummit.com

Forward Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Bimergen Energy Corporation’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the final prospectus related to the public offering filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Bimergen Energy Corporation undertakes no duty to update such information except as required under applicable law.

Media Contact:

Dave Gentry

RedChip Companies Inc.
1-407-644-4256 | 1-800-REDCHIP (733-2447)
[email protected]